Capstan Therapeutics, Inc. — Form D
Capstan Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-20. The offering totals $102.0M, of which $76.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-03-20
- Form: D
- Accession: 0002015437-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $102.0M
- Amount sold: $76.5M
- Remaining: $25.5M
- Investors: 14
- Date of first sale: 2022-06-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508076
Issuer
- Name: Capstan Therapeutics, Inc.
- CIK: 0002015437
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 9880 CAMPUS POINT DRIVE, SUITE 220, SAN DIEGO, CA, 92121
- Phone: 858-314-9188
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Michael Baran | Director | New York, NY |
| Nandita Shangari | Director | Boston, MA |
| Karen Smith | Director | San Diego, CA |
| Adrian Bot | Executive Officer | San Diego, CA |
| Priya Karmali | Executive Officer | San Diego, CA |
| Justin Thacker | Executive Officer | San Diego, CA |
| Fabio Pucci | Director | Houston, TX |
| Athena Countouriotis | Director | San Diego, CA |
| Erez Chimovits | Director | NESS ZIONA, L3 |
| Michal Silverberg | Director | Watertown, MA |
| Laura Shawver | Director | Del Mar, CA |
| Laura Shawver | Executive Officer | Del Mar, CA |
| Ramin Farzaneh-Far | Executive Officer | San Diego, CA |
| Rajul Jain | Director | South San Francisco, CA |
| Nanna Luneborg | Director | San Diego, CA |
Other filings by this issuer (2)
More